Combinations of cocaine with other dopamine uptake inhibitors: Assessment of additivity

Journal of Pharmacology and Experimental Therapeutics

Volumn 330, Issue 3, 2009, Pages 802-809

  Tanda, Gianluigi ^a   Newman, Amy Hauck ^a   Ebbs, Aaron L ^a   Tronci, Valeria ^a   Green, Jennifer L ^a   Tallarida, Ronald J ^b   Katz, Jonathan L ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [BIS(4 FLUOROPHENYL)METHOXY] 8 BUTYL 8 AZABICYCLO[3.2.1]OCTANE; 3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; BENZATROPINE; COCAINE; DOPAMINE; DOPAMINE TRANSPORTER; DOPAMINE UPTAKE INHIBITOR; JHW 007; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DIALYSATE; DOPAMINE UPTAKE; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; DRUG PROTEIN BINDING; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ANIMALS; BENZTROPINE; COCAINE; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; MALE; MICE; MICRODIALYSIS; NUCLEUS ACCUMBENS;

EID: 70349124236     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.154302     Document Type: Article

References (41)

1. Agoston GE, Wu JH, Izenwasser S, George C, Katz J, Kline RH, and Newman AH (1997) Novel N-substituted 3α-[bis(4′-fluorophenyl)methoxy] tropane analogues: selective ligands for the dopamine transporter. J Med Chem 40:4329-4339. (Pubitemid 28042312)
2. Baumann MH, Char GU, De Costa BR, Rice KC, and Rothman RB (1994) GBR12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat. J Pharmacol Exp Ther 271:1216-1222. (Pubitemid 24382624)
3. Berger P, Elsworth JD, Reith ME, Tanen D, and Roth RH (1990) Complex interaction of cocaine with the dopamine uptake carrier. Eur J Pharmacol 176:251-252. (Pubitemid 20041303)
4. Bergman J, Madras BK, Johnson SE, and Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates III self-administration by squirrel monkeys. J Pharmacol Exp Ther 251:150-155. (Pubitemid 19261957)
5. Beuming T, Kniazeff J, Bergmann ML, Shi L, Gracia L, Raniszewska K, Newman AH, Javitch JA, Weinstein H, Gether U, et al. (2008) The binding sites for cocaine and dopamine in the dopamine transporter overlap. Nat Neurosci 11:780-789.
6. Bubar MJ, McMahon LR, De Deurwaerdère P, Spampinato U, and Cunningham KA (2003) Selective serotonin reuptake inhibitors enhance cocaine-induced locomotor activity and dopamine release in the nucleus accumbens. Neuropharmacology 44:342-353. (Pubitemid 36246489)
7. Carboni E, Silvagni A, Vacca C, and Di Chiara G (2006) Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex. J Neurochem 96:473-481.
8. Carroll FI, Howell LL, and Kuhar MJ (1999) Pharmacotherapies for treatment of cocaine abuse: preclinical aspects. J Med Chem 42:2721-2736. (Pubitemid 29370417)
9. Desai RI, Kopajtic TA, Koffarnus M, Newman AH, and Katz JL (2005) Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine. J Neurosci 25:1889-1893. (Pubitemid 40289393)
10. Di Chiara G, Tanda G, Bassareo V, Pontieri F, Acquas E, Fenu S, Cadoni C, and Carboni E (1999) Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine. Ann N Y Acad Sci 877:461-485. (Pubitemid 29351873)
11. Finney DJ (1964) Statistical Method in Biological Assay, 2nd ed, Hafner, New York.
12. Gifford AN, Bergmann JS, and Johnson KM (1993) GBR 12909 fails to antagonize cocaine-induced elevation of dopamine in striatal slices. Drug Alcohol Depend 32:65-71. (Pubitemid 23113272)
13. Ginsburg BC, Kimmel HL, Carroll FI, Goodman MM, and Howell LL (2005) Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys. Pharmacol Biochem Behav 80:481-491.
14. Grabovsky Y and Tallarida RJ (2004) Isobolographic analysis for combinations of a full and partial agonist: curved isoboles. J Pharmacol Exp Ther 310:981-986. (Pubitemid 39108918)
15. Hiranita T, Soto PL, Newman AH, and Katz JL (2009) Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors. J Pharmacol Exp Ther 329:677-686.
16. Holtzman SG (2001) Differential interaction of GBR 12909 a dopamine uptake inhibitor with cocaine and methamphetamine in rats discriminating cocaine. Psychopharmacology 155:180-186.
17. Howell LL and Wilcox KM (2001) The dopamine transporter and cocaine medication development: drug self-administration in nonhuman primates. J Pharmacol Exp Ther 298:1-6.
18. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
19. Katz JL, Kopajtic TA, Agoston GE, and Newman AH (2004) Effects of N-substituted analogues of benztropine: diminished cocaine-like effects in dopamine transporter ligands. J Pharmacol Exp Ther 309:650-660.
20. 3H]JHW 007 a dopamine transporter ligand that blocks the effects of cocaine In: LS Harris, editor. Proceedings of the 67th Annual Scientific Meeting of the College on Problems of Drug Dependence; 2005 June 18-23; Orlando, FL. College of Drug Dependence, Philadelphia, PA.
21. Kuhar MJ, Ritz MC, and Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299-302.
22. Li SM, Campbell BL, and Katz JL (2006) Interactions of cocaine with dopamine uptake inhibitors or dopamine releasers in rats discriminating cocaine. J Pharmacol Exp Ther 317:1088-1096.
23. Loland CJ, Desai RI, Zou MF, Cao J, Grundt P, Gerstbrein K, Sitte HH, Newman AH, Katz JL, and Gether U (2008) Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors. Mol Pharmacol 73:813-823.
24. Newman AH and Katz JL (2009) Atypical dopamine uptake inhibitors that provide clues about cocaine's mechanism at the dopamine transporter, in Topics in Medicinal Chemistry, Volume 4: Transporters as Targets for Drugs (Napier S and Bingham M, eds), Springer, Berlin.
25. Paxinos G and Franklin KBJ (2001) The Mouse Brain in Stereotaxic Coordinates, 2nd ed, Academic Press, New York.
26. Pontieri FE, Tanda G, and Di Chiara G (1995) Intravenous cocaine morphine and amphetamine preferentially increase extracellular dopamine in the "hell" as compared with the "core" of the rat nucleus accumbens. Proc Natl Acad Sci U S A 92:12304-12308.
27. Reith ME, Berfield JL, Wang LC, Ferrer JV, and Javitch JA (2001) The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter. J Biol Chem 276:29012-29018. (Pubitemid 37451986)
28. 3H]cocaine in mouse striatum and cerebral cortex have different dissociation kinetics. J Neurochem 46:309-312.
29. Ritz MC, Lamb RJ, Goldberg SR, and Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219-1223.
30. Rothman RB, Mele A, Reid AA, Akunne HC, Greig N, Thurkauf A, de Costa BR, Rice KC, and Pert A (1991) GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine. Pharmacol Biochem Behav 40:387-397.
31. Snedecor GW and Cochran WG (1967) Statistical Methods, 6th ed, Iowa State University Press, Ames, IA.
32. Tallarida RJ (2000) Drug Synergism and Dose-Effect Data Analysis. CRC/Chapman-Hall, Boca Raton, FL.
33. Tallarida RJ (2007) Interactions between drugs and occupied receptors. Pharmacol Ther 113:197-209.
34. Tanda G, Ebbs AL, Kopajtic TA, Elias LM, Campbell BL, Newman AH, and Katz JL (2007) Effects of muscarinic M1 receptor blockade on cocaine-induced elevations of brain dopamine levels and locomotor behavior in rats. J Pharmacol Exp Ther 321:334-344. (Pubitemid 46456955)
35. Tanda G, Ebbs A, Newman AH, and Katz JL (2005) Effects of 4′-chloro-3α-(diphenylmethoxy)-tropane on mesostriatal mesocortical and mesolimbic dopamine transmission: comparison with effects of cocaine. J Pharmacol Exp Ther 313:613-620. (Pubitemid 40604161)
36. Tanda G and Katz JL (2007) Muscarinic preferential M1 receptor antagonists minimally alter the discriminative-stimulus effects of cocaine in rats. Pharmacol Biochem Behav 87:400-404. (Pubitemid 47243672)
37. Tanda G, Ebbs AL, Kopajtic TA, Elias LM, Campbell BL, Newman AH, and Katz JL (2007) Effects of muscarinic M1 receptor blockade on cocaine-induced elevations of brain dopamine levels and locomotor behavior in rats. J Pharmacol Exp Ther 321:334-344. (Pubitemid 46456955)
38. Tanda G, Garcés-Ramírez L, Green JL, Hiranita T and Katz JL (2009) Effects of acute administration of sigma receptor ligands on mesolimbic dopamine neurotransmission in rats. FASEB J 23:745.4.
39. Tolliver BK, Newman AH, Katz JL, Ho LB, Fox LM, Hsu K Jr, and Berger SP (1999) Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo. J Pharmacol Exp Ther 289:110-122.
40. Volkow ND, Wang GJ, Fischman MW, Foltin RW, Fowler JS, Abumrad NN, Vitkun S, Logan J, Gatley SJ, Pappas N, et al. (1997) Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386:827-830. (Pubitemid 27181255)
41. Wilcox KM, Lindsey KP, Votaw JR, Goodman MM, Martarello L, Carroll FI, and Howell LL (2002) Self-administration of cocaine and the cocaine analog RTI-113: Relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys. Synapse 43:78-85. (Pubitemid 33115670)